Barclays’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,348
| Closed | -$108K | – | 4431 |
|
|
2024
Q1 | $108K | Sell |
7,348
-7,032
| -49% | -$103K | ﹤0.01% | 3616 |
|
|
2023
Q4 | $193K | Buy |
14,380
+12,535
| +679% | +$168K | ﹤0.01% | 3523 |
|
|
2023
Q3 | $23K | Sell |
1,845
-3,772
| -67% | -$47K | ﹤0.01% | 3878 |
|
|
2023
Q2 | $69K | Buy |
5,617
+179
| +3% | +$2.2K | ﹤0.01% | 3550 |
|
|
2023
Q1 | $67K | Buy |
5,438
+5,303
| +3,928% | +$65.3K | ﹤0.01% | 3696 |
|
|
2022
Q4 | $2K | Buy |
+135
| New | +$2K | ﹤0.01% | 4308 |
|
|
2021
Q2 | – | Sell |
-320
| Closed | -$2K | – | 4339 |
|
|
2021
Q1 | $2K | Buy |
+320
| New | +$2K | ﹤0.01% | 3844 |
|
|
2020
Q1 | – | Sell |
-8
| Closed | – | – | 4140 |
|
|
2019
Q4 | $0 | Sell |
8
-42
| -84% | – | ﹤0.01% | 4539 |
|
|
2019
Q3 | $0 | Sell |
50
-14
| -22% | – | ﹤0.01% | 4693 |
|
|
2019
Q2 | $0 | Hold |
64
| – | – | ﹤0.01% | 4639 |
|
|
2019
Q1 | $0 | Hold |
64
| – | – | ﹤0.01% | 4596 |
|
|
2018
Q4 | $0 | Sell |
64
-889
| -93% | – | ﹤0.01% | 4709 |
|
|
2018
Q3 | $4K | Sell |
953
-22,832
| -96% | -$95.8K | ﹤0.01% | 4115 |
|
|
2018
Q2 | $92K | Buy |
23,785
+20,385
| +600% | +$78.8K | ﹤0.01% | 3100 |
|
|
2018
Q1 | $21K | Buy |
3,400
+292
| +9% | +$1.8K | ﹤0.01% | 3837 |
|
|
2017
Q4 | $25K | Buy |
3,108
+2,729
| +720% | +$22K | ﹤0.01% | 3638 |
|
|
2017
Q3 | $4K | Buy |
379
+252
| +198% | +$2.66K | ﹤0.01% | 3769 |
|
|
2017
Q2 | $1K | Sell |
127
-737
| -85% | -$5.8K | ﹤0.01% | 3831 |
|
|
2017
Q1 | $21K | Sell |
864
-6,624
| -88% | -$161K | ﹤0.01% | 3365 |
|
|
2016
Q4 | $241K | Sell |
7,488
-7,776
| -51% | -$250K | ﹤0.01% | 2211 |
|
|
2016
Q3 | $762K | Buy |
+15,264
| New | +$762K | ﹤0.01% | 1547 |
|
|
2016
Q2 | – | Sell |
-753
| Closed | -$47K | – | 4058 |
|
|
2016
Q1 | $47K | Buy |
753
+518
| +220% | +$32.3K | ﹤0.01% | 2558 |
|
|
2015
Q4 | $13K | Sell |
235
-3,639
| -94% | -$201K | ﹤0.01% | 2775 |
|
|
2015
Q3 | $244K | Buy |
3,874
+2,451
| +172% | +$154K | ﹤0.01% | 2049 |
|
|
2015
Q2 | $134K | Sell |
1,423
-15,741
| -92% | -$1.48M | ﹤0.01% | 2242 |
|
|
2015
Q1 | $1.49M | Buy |
17,164
+16,123
| +1,549% | +$1.39M | ﹤0.01% | 1408 |
|
|
2014
Q4 | $89K | Sell |
1,041
-1,005
| -49% | -$85.9K | ﹤0.01% | 2761 |
|
|
2014
Q3 | $129K | Sell |
2,046
-4,064
| -67% | -$256K | ﹤0.01% | 2526 |
|
|
2014
Q2 | $336K | Sell |
6,110
-116
| -2% | -$6.38K | ﹤0.01% | 2176 |
|
|
2014
Q1 | $246K | Sell |
6,226
-828
| -12% | -$32.7K | ﹤0.01% | 2287 |
|
|
2013
Q4 | $278K | Buy |
7,054
+6,341
| +889% | +$250K | ﹤0.01% | 2447 |
|
|
2013
Q3 | $17K | Sell |
713
-63
| -8% | -$1.5K | ﹤0.01% | 3533 |
|
|
2013
Q2 | $41K | Buy |
+776
| New | +$41K | ﹤0.01% | 3425 |
|